Want to see HK:1789 full AI Analyst Report?
1789 Stock Chart & Stats
HK$5.91
-HK$0.05(-1.15%)
At close: 4:00 PM EST
HK$5.91
-HK$0.05(-1.15%)
Day’s Range― - ―
52-Week RangeHK$4.75 - HK$7.15
Previous CloseN/A
Volume3.85M
Average Volume (3M)3.45M
Market Cap
HK$5.39B
Enterprise ValueHK$4.36K
Total Cash (Recent Filing)HK$1.25B
Total Debt (Recent Filing)HK$78.25M
Price to Earnings (P/E)12.2
Beta1.04
Next Earnings
Mar 31, 2027EPS Estimate
0.22Next Dividend Ex-DateN/A
Dividend Yield2.43%
Share Statistics
EPS (TTM)0.34
Shares Outstanding1,109,980,300
10 Day Avg. Volume3,711,054
30 Day Avg. Volume3,450,927
Financial Highlights & Ratios
PEG Ratio0.85
Price to Book (P/B)1.97
Price to Sales (P/S)3.87
P/FCF Ratio18.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$17.21Price Target Upside191.20% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.37
Revenue Forecast (FY)HK$1.68B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthPositive revenue growth indicates ongoing expansion in demand for the company’s orthopedic implants and related solutions. If sustained, this can broaden hospital and surgeon adoption, support operating leverage, and provide a durable base for reinvestment in products and market development over the next several quarters.
Strong MarginsHigh gross, operating, and net margins show that the business retains substantial economics after product costs and operating expenses. This profitability provides resilience, supports internal funding of development and commercial activity, and indicates meaningful cost discipline in the orthopedic device model.
Conservative Balance SheetVery low leverage and a growing equity base give AK Medical considerable financial flexibility. The company is less exposed to interest burdens and refinancing pressure, allowing more capacity to absorb operating variability or fund expansion without relying heavily on additional borrowing.
Bears Say
Cash-Flow VolatilityThe sharp 2023 cash-flow downturn demonstrates that reported profitability has not converted consistently into cash. Although later cash generation improved, recurring volatility can constrain internally funded investment, complicate capital planning, and make earnings quality less dependable during weaker operating periods.
Uneven Revenue GrowthRevenue growth has been inconsistent across recent years rather than steadily compounding. This uneven trajectory may reflect variability in procedure volumes, product mix, or procurement timing, making it harder to plan capacity and sustain operating leverage even though the longer-term revenue base has expanded.
Returns Below PeakImproving return on equity is constructive, but remaining below the 2020 high indicates that profitability on the capital base has not fully recovered its prior efficiency. This limits the evidence for sustained peak earnings productivity and places greater importance on future growth and capital deployment.
AK Medical Holdings Ltd. News
1789 FAQ
What was AK Medical Holdings Ltd.’s price range in the past 12 months?
AK Medical Holdings Ltd. lowest stock price was HK$4.75 and its highest was HK$7.15 in the past 12 months.
What is AK Medical Holdings Ltd.’s market cap?
AK Medical Holdings Ltd.’s market cap is HK$5.39B.
When is AK Medical Holdings Ltd.’s upcoming earnings report date?
AK Medical Holdings Ltd.’s upcoming earnings report date is Mar 31, 2027 which is in 191 days.
How were AK Medical Holdings Ltd.’s earnings last quarter?
AK Medical Holdings Ltd. released its earnings results on Aug 26, 2026. The company reported HK$0.206 earnings per share for the quarter, beating the consensus estimate of HK$0.198 by HK$0.008.
Is AK Medical Holdings Ltd. overvalued?
According to Wall Street analysts AK Medical Holdings Ltd.’s price is currently Undervalued.
Does AK Medical Holdings Ltd. pay dividends?
AK Medical Holdings Ltd. pays a Annually dividend of HK$0.118 which represents an annual dividend yield of 2.43%. See more information on AK Medical Holdings Ltd. dividends here
What is AK Medical Holdings Ltd.’s EPS estimate?
AK Medical Holdings Ltd.’s EPS estimate is 0.22.
How many shares outstanding does AK Medical Holdings Ltd. have?
AK Medical Holdings Ltd. has 1,109,980,300 shares outstanding.
What happened to AK Medical Holdings Ltd.’s price movement after its last earnings report?
AK Medical Holdings Ltd. reported an EPS of HK$0.206 in its last earnings report, beating expectations of HK$0.198. Following the earnings report the stock price went down -1.778%.
Which hedge fund is a major shareholder of AK Medical Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:1789
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AK Medical Holdings Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.27%
12-Months-Change
Fundamentals
Return on Equity
2.43%
Trailing 12-Months
Asset Growth
4.98%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
AK Medical Holdings Ltd.
AK Medical Holdings Limited, an investment holding enterprise, specializes in the research, development, production, and worldwide commercialization of orthopedic joint implants and related medical devices under the AK Medical brand. Its comprehensive product offerings encompass conventional knee, hip, and spine replacement implants, as well as advanced 3D-printed solutions like hip implants, artificial vertebral bodies, and spinal interbody cages. The company further expands its operations by distributing orthopedic products from third-party manufacturers and by fabricating surgical instruments and medical irrigators. Its diverse client base spans distributors, hospitals, physicians, surgeons, and directly serves patients. Established in Beijing, People's Republic of China, in 2003, AK Medical Holdings Limited functions as a subsidiary of Ximalaya Limited.
1789 Stock 12 Month Forecast
Average Price Target
HK$17.21
▲(191.20% Upside)
Technical Analysis
MicroPort Scientific
―
LifeTech Scientific Corporation
―
MicroPort CardioFlow Medtech Corp.
―
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
―
Venus Medtech (Hangzhou), Inc. Class H
―